Neuroleptic malignant syndrome

Abstract
We report the 1st case of neuroleptic malignant syndrome occurring in a patient receiving desipramine, a tricyclic antidepressant, with no exposure to neuroleptics. Our case suggests that this syndrome may be caused by a central imbalance between norepinephrine and dopamine, and not by dopamine depletion alone.

This publication has 2 references indexed in Scilit: